University of Hertfordshire

From the same journal

By the same authors

The Unregulated Psychoactive Compound: ‘Benzo Fury’

Research output: Contribution to journalMeeting abstractpeer-review

Standard

The Unregulated Psychoactive Compound: ‘Benzo Fury’. / Gimeno Clemente, Carla; Chiappini, Stephania; Claridge, Hugh; Corkery, John; Goodair, Christine; Loi, Barbara; Schifano, Fabrizio.

In: Current Drug Abuse Reviews, Vol. 6, No. 4, 45, 12.2013, p. 285.

Research output: Contribution to journalMeeting abstractpeer-review

Harvard

Gimeno Clemente, C, Chiappini, S, Claridge, H, Corkery, J, Goodair, C, Loi, B & Schifano, F 2013, 'The Unregulated Psychoactive Compound: ‘Benzo Fury’', Current Drug Abuse Reviews, vol. 6, no. 4, 45, pp. 285. https://doi.org/10.2174/187447370604140616124624

APA

Vancouver

Gimeno Clemente C, Chiappini S, Claridge H, Corkery J, Goodair C, Loi B et al. The Unregulated Psychoactive Compound: ‘Benzo Fury’. Current Drug Abuse Reviews. 2013 Dec;6(4):285. 45. https://doi.org/10.2174/187447370604140616124624

Author

Gimeno Clemente, Carla ; Chiappini, Stephania ; Claridge, Hugh ; Corkery, John ; Goodair, Christine ; Loi, Barbara ; Schifano, Fabrizio. / The Unregulated Psychoactive Compound: ‘Benzo Fury’. In: Current Drug Abuse Reviews. 2013 ; Vol. 6, No. 4. pp. 285.

Bibtex

@article{629a0b846f9f4908803b3f8f1ee3253d,
title = "The Unregulated Psychoactive Compound: {\textquoteleft}Benzo Fury{\textquoteright}",
abstract = "Introduction: The {\textquoteleft}legal high{\textquoteright} {\textquoteleft}Benzo Fury{\textquoteright} [1-(benzofuran-5-yl)propan-2-amine (5-APB) and 1-(benzofuran-6-yl)propan-2-amine (6-APB)] is an unregulated psychoactive compound which has similar effects as known controlled drugs like amphetamines and ecstasy (with hallucinogenic and stimulant properties). It is known to pose significant health risks, such ascausing anxiety, sinus tachycardia, hypertension, and QT prolongation. Furthermore, it is easily obtained from the internet.Methods: A systematic review based on PubMed and Medline literature was conducted. Deaths involving {\textquoteleft}Benzo Fury{\textquoteright} (implicated in death and/or identified at post mortem toxicology) in the UK from 1997-2012 were identified from the national programme on Substance Abuse Deaths (np-SAD) database. The programme periodically receives information regarding drugrelated deaths in the UK submitted voluntarily by Coroners, the Northern Ireland Statistics and Research Agency, and the Scottish Crime and Drug Enforcement Agency. The general characteristics of these fatalities were analysed.Results: Ten cases were found with {\textquoteleft}Benzo Fury{\textquoteright} identified at post mortem and it was directly implicated in eight of these deaths. In nine cases, {\textquoteleft}Benzo Fury{\textquoteright} was found in combination with other psychoactive substances. All deaths occurred between 2011-12; the median age at death was 24 years; the majority were male (8/10); and where ethnicity was known, all were white.Conclusions: Our findings indicate a need for a Public Health education campaign on the risks of {\textquoteleft}Benzo Fury{\textquoteright} consumption, especially targeting young users and drugs education workers. Further research into the toxicity of {\textquoteleft}Benzo Fury{\textquoteright} and the risks associated with its consumption is also needed.",
author = "{Gimeno Clemente}, Carla and Stephania Chiappini and Hugh Claridge and John Corkery and Christine Goodair and Barbara Loi and Fabrizio Schifano",
year = "2013",
month = dec,
doi = "10.2174/187447370604140616124624",
language = "English",
volume = "6",
pages = "285",
journal = "Current Drug Abuse Reviews",
issn = "1874-4737",
publisher = "Bentham Science Publishers B.V.",
number = "4",
note = "Second International Conference on Novel Psychoactive Substances (NPS) ; Conference date: 12-09-2013 Through 13-09-2013",

}

RIS

TY - JOUR

T1 - The Unregulated Psychoactive Compound: ‘Benzo Fury’

AU - Gimeno Clemente, Carla

AU - Chiappini, Stephania

AU - Claridge, Hugh

AU - Corkery, John

AU - Goodair, Christine

AU - Loi, Barbara

AU - Schifano, Fabrizio

PY - 2013/12

Y1 - 2013/12

N2 - Introduction: The ‘legal high’ ‘Benzo Fury’ [1-(benzofuran-5-yl)propan-2-amine (5-APB) and 1-(benzofuran-6-yl)propan-2-amine (6-APB)] is an unregulated psychoactive compound which has similar effects as known controlled drugs like amphetamines and ecstasy (with hallucinogenic and stimulant properties). It is known to pose significant health risks, such ascausing anxiety, sinus tachycardia, hypertension, and QT prolongation. Furthermore, it is easily obtained from the internet.Methods: A systematic review based on PubMed and Medline literature was conducted. Deaths involving ‘Benzo Fury’ (implicated in death and/or identified at post mortem toxicology) in the UK from 1997-2012 were identified from the national programme on Substance Abuse Deaths (np-SAD) database. The programme periodically receives information regarding drugrelated deaths in the UK submitted voluntarily by Coroners, the Northern Ireland Statistics and Research Agency, and the Scottish Crime and Drug Enforcement Agency. The general characteristics of these fatalities were analysed.Results: Ten cases were found with ‘Benzo Fury’ identified at post mortem and it was directly implicated in eight of these deaths. In nine cases, ‘Benzo Fury’ was found in combination with other psychoactive substances. All deaths occurred between 2011-12; the median age at death was 24 years; the majority were male (8/10); and where ethnicity was known, all were white.Conclusions: Our findings indicate a need for a Public Health education campaign on the risks of ‘Benzo Fury’ consumption, especially targeting young users and drugs education workers. Further research into the toxicity of ‘Benzo Fury’ and the risks associated with its consumption is also needed.

AB - Introduction: The ‘legal high’ ‘Benzo Fury’ [1-(benzofuran-5-yl)propan-2-amine (5-APB) and 1-(benzofuran-6-yl)propan-2-amine (6-APB)] is an unregulated psychoactive compound which has similar effects as known controlled drugs like amphetamines and ecstasy (with hallucinogenic and stimulant properties). It is known to pose significant health risks, such ascausing anxiety, sinus tachycardia, hypertension, and QT prolongation. Furthermore, it is easily obtained from the internet.Methods: A systematic review based on PubMed and Medline literature was conducted. Deaths involving ‘Benzo Fury’ (implicated in death and/or identified at post mortem toxicology) in the UK from 1997-2012 were identified from the national programme on Substance Abuse Deaths (np-SAD) database. The programme periodically receives information regarding drugrelated deaths in the UK submitted voluntarily by Coroners, the Northern Ireland Statistics and Research Agency, and the Scottish Crime and Drug Enforcement Agency. The general characteristics of these fatalities were analysed.Results: Ten cases were found with ‘Benzo Fury’ identified at post mortem and it was directly implicated in eight of these deaths. In nine cases, ‘Benzo Fury’ was found in combination with other psychoactive substances. All deaths occurred between 2011-12; the median age at death was 24 years; the majority were male (8/10); and where ethnicity was known, all were white.Conclusions: Our findings indicate a need for a Public Health education campaign on the risks of ‘Benzo Fury’ consumption, especially targeting young users and drugs education workers. Further research into the toxicity of ‘Benzo Fury’ and the risks associated with its consumption is also needed.

U2 - 10.2174/187447370604140616124624

DO - 10.2174/187447370604140616124624

M3 - Meeting abstract

VL - 6

SP - 285

JO - Current Drug Abuse Reviews

JF - Current Drug Abuse Reviews

SN - 1874-4737

IS - 4

M1 - 45

T2 - Second International Conference on Novel Psychoactive Substances (NPS)

Y2 - 12 September 2013 through 13 September 2013

ER -